Previous Article | Next Article 
Journal of Virology, February 2001, p. 1816-1823, Vol. 75, No. 4
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.4.1816-1823.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Temperature-Sensitive Transformation by an Abelson
Virus Mutant Encoding an Altered SH2 Domain
Celine A.
Mainville,1,2
Kalindi
Parmar,1,
Indira
Unnikrishnan,1
Li
Gong,3
Glen D.
Raffel,3,4,
and
Naomi
Rosenberg1,2,3,4,*
Departments of
Pathology1 and Molecular Biology and
Microbiology,3 Medical Scientist
Training Program,4 and Graduate Program
in Immunology,2 Tufts University School of
Medicine, Boston, Massachusetts 02111
Received 17 August 2000/Accepted 20 November 2000
 |
ABSTRACT |
Abelson murine leukemia virus (Ab-MLV) encodes the v-Abl protein
tyrosine kinase and induces transformation of immortalized fibroblast
lines and pre-B cells. Temperature-sensitive mutations affecting the
kinase domain of the protein have demonstrated that the kinase activity
is absolutely required for transformation. Despite this requirement,
mutations affecting other regions of v-Abl modulate transformation
activity. The SH2 domain and the highly conserved FLVRES motif within
it form a phosphotyrosine-binding pocket that is required for
interactions between the kinase and cellular substrates. To understand
the impact of SH2 alterations on Ab-MLV-mediated transformation, we
studied the Ab-MLV mutant P120/R273K. This mutant encodes a v-Abl
protein in which the
B5 arginine at the base of the
phosphotyrosine-binding pocket has been replaced by a lysine.
Unexpectedly, infection of NIH 3T3 or pre-B cells with P120/R273K
revealed a temperature-dependent transformation phenotype. At 34°C,
P120/R273K transformed about 10-fold fewer cells than wild-type virus
of equivalent titer; at 39.5°C, 300-fold fewer NIH 3T3 cells were
transformed and pre-B cells were refractory to transformation.
Temperature-dependent transformation was accompanied by decreased
phosphorylation of Shc, a protein that interacts with the v-Abl SH2 and
links the protein to Ras, and decreased induction of c-Myc expression.
These data suggest that alteration of the FLVRES pocket affects the ability of v-Abl to interact with at least some of its substrates in a
temperature-dependent fashion and identify a novel type of temperature-sensitive Abelson virus.
 |
INTRODUCTION |
Expression of the protein tyrosine
kinase encoded by the v-abl oncogene of Abelson murine
leukemia virus (Ab-MLV) induces transformation of pre-B cells and
immortalized fibroblast lines in vitro and causes pre-B-cell lymphoma
in mice (37). Although the tyrosine kinase activity of the
v-Abl protein is absolutely required for transformation, the SH2
domain, a region involved in phosphotyrosine-dependent interactions
(11, 48), also plays an important role in the process.
This domain contains a phosphotyrosine-binding pocket characterized by
the amino acids FLVRES; replacing Arg
B5, located at the base of the
pocket, with a Lys or other residues drastically affects the ability of
activated c-Abl proteins and Bcr/Abl proteins to transform immortalized
fibroblast lines (1, 28). These substitutions drastically
reduce binding of tyrosine-phosphorylated peptides to SH2 domains;
those affecting other pocket residues have more modest effects on
binding and variable effects on transformation mediated by Abl or by
Src, which has a closely related SH2 domain (3-5, 13, 28, 44,
47).
Although the FLVRES motif and Arg
B5 play a dominant role in
SH2-mediated phosphopeptide binding, they do not fully account for the
specificity of SH2 domain substrate interaction. Residues within the
SH2 domain that contact residues C terminal to the phosphotyrosine on
the target protein are one way in which specificity of substrate
interaction may be controlled (26, 43). However, analyses
of interactions between Src SH2 domain mutants and peptides deviating
from its consensus pYEEI peptide binding sequence have suggested that
specificity reflects more complex interactions (5).
Parameters such as intracellular location (which likely affects the
proximity of the kinase and particular substrates), the ability to
assemble signaling complexes, and interactions with other domains of
the kinase are likely to influence substrate selection and play a role
in SH2 domain function.
Identifying substrates that interact with SH2 domains and probing the
way these interactions contribute to transformation provide one
approach to understanding how SH2-mediated signaling specificity
contributes to host-virus interaction. For the v-Abl protein, the Shc
adapter molecule is one such substrate (31, 35). Shc can
complex with Grb2 and the G-protein exchange factor, mSos, facilitating
the activation of Ras (14, 27). The last event is required
for Abl-mediated transformation (39). Activation of Ras
stimulates multiple downstream effector proteins, including c-Myc
(21-23), another protein that is critical for
Abl-mediated transformation (38). Consistent with the idea
that signals requiring an intact SH2 domain pass through Ras and lead
to c-Myc (52), transformation of RAT-1 cells by Bcr/Abl
proteins containing an altered FLVRES motif is complemented by
expression of c-Myc (1, 25).
To understand how the v-Abl SH2 domain contributes to transformation
and downstream signaling, we examined the biological properties of the
P120/R273K mutant. This mutant encodes a v-Abl protein in which a Lys
is substituted for Arg
B5. Unexpectedly, P120/R273K retained
significant transformation potential when assayed at 34°C but was
compromised for transformation at 39.5°C. These defects were
correlated to deficiencies in interactions with Shc and decreased
stimulation of c-Myc. These data reveal a novel type of Ab-MLV
temperature-sensitive (ts) mutant and a previously
unappreciated effect of temperature on v-Abl proteins with an altered
SH2 domain.
 |
MATERIALS AND METHODS |
Cells and viruses.
NIH 3T3 cells were grown in Dulbecco's
modified Eagle's medium supplemented to contain 10% calf serum
(Sigma); Ab-MLV-transformed NIH 3T3 cells and 293T cells
(15) were grown in Dulbecco's modified Eagle's medium
supplemented to contain 10% fetal calf serum (Intergen). Ab-MLV-transformed pre-B-cell lines were grown in RPMI 1640 medium supplemented to contain 20% fetal calf serum and 50 µM
2-mercaptoethanol (Sigma). The ts Ab-MuLV-transformed
pre-B-cell line 7C411 was derived by infecting bone marrow cells with
the ts Ab-MuLV strain P70/H590 (17) and
maintained at 34°C, the permissive temperature for the ts
Ab-MuLV mutants; the nonpermissive temperature used was 39.5°C.
Retroviral stocks were prepared using transient transfection of
293T cells as described elsewhere (49). The
pSR
-MSVtkneo vector (30) or the pMIG vector
(19, 46) was used to express the different Ab-MLV strains.
In the pMIG vector, green fluorescent protein (GFP) expression is
mediated by an internal ribosome entry site (IRES) sequence and
gag/v-abl sequences are cloned upstream of the
IRES sequence. Infectivity was evaluated by Western blot analysis of
the levels of v-Abl protein in lysates of NIH 3T3 cells that had been
infected for 48 to 72 h with the Ab-MLV stocks prepared with the
pSR
vector (33) or by using fluorescence-activated cell
sorting (FACS) to score the frequency of GFP-positive NIH 3T3 cells
24 h after infection with Ab-MLV stocks prepared using the pMIG
vector. The titers of virus were also determined using the NIH 3T3 cell
transformation assay (40). Bone marrow transformation assays were done as described previously (36). Macroscopic
pre-B-cell colonies were counted 10 to 12 days later. For some assays,
the infected cells were plated directly into RPMI 1640 medium
supplemented to contain 20% fetal calf serum and 50 µM
2-mercaptoethanol. Cultures were scored as transformed when the number
of nonadherent pre-B cells exceeded 2 × 106 per ml of
culture medium (1, 29). To obtain derivatives of 7C411
cells expressing wild-type or Ab-MLV mutants, 106 cells
were infected in the presence of 4 µg of Polybrene per ml for 4 h and plated in standard growth medium; 24 h later, 1 mg of G418
per ml was added to the medium to select for cells expressing the
superinfecting virus, and the cells were plated in 96-well plates.
Individual clones of G418-resistant cells were isolated 7 to 14 days
later. Cell cycle parameters were monitored by analyzing propidium
iodide-stained cells using a FACScan and Modfit LT software
(8).
Construction of viral strains.
pSR
-P120 and the kinase
negative mutant P120/D484N have been described elsewhere (35,
49). The P120/R273K mutant was created by PCR using pUC120 as a
template (18) and one primer which changed the codon for
Arg-273 to a Lys codon. The fragment containing the mutation was
subcloned and then shuttled into pSR
-P120 as a
BstEII-DraIII (bases 725 to 2111 of the P120
genome) fragment. Ab-MLV P120 and P120/R273K were introduced into pMIG
by shuttling the viral sequences contained on an EcoRI
fragment from the pSR
vectors into the EcoRI cloning site
of pMIG (19, 46). The presence of all mutations and the
integrity of all sequences derived by PCR amplification were examined
in the DNA Facility, Department of Physiology, Tufts University School
of Medicine.
Protein analysis.
Cells were treated with lysis buffer (10 mM Tris [pH 7.4], 1% sodium dodecyl sulfate [SDS], 1 mM sodium
orthovanadate, 1 mM phenylmethylsulfonyl fluoride [PMSF]) as
described previously (9, 32). Protein was quantitated
using a bicinchoninic acid protein assay kit (Pierce), and 50 µg of
each sample was fractionated through SDS-polyacrylamide gels. The
proteins were transferred to a polyvinylidene difluoride membrane (U.S.
Biochemicals), and the blots were treated according to the
Western-Light kit protocol (Tropix) using alkaline
phosphatase-conjugated secondary antibodies and the CSPD substrate
(Tropix). For immunoprecipitation with anti-p62 Dok antibodies, cells
were resuspended in ice-cold TNN lysis buffer (150 mM NaCl, 50 mM Tris
[pH 8], 1% NP-40, 10 µg of leupeptin per ml, 1 mM orthovanadate,
and 1 mM PMSF); for immunoprecipitation with anti-Shc antibodies, cells
were resuspended in radioimmunoprecipitation assay buffer (10 mM sodium
phosphate [pH 7], 150 mM NaCl, 0.1% SDS, 50 mM NaF, 1% NP-40, 0.5%
sodium deoxycholate, 2 mM EDTA, 1 mM sodium orthovanadate, 1 mM PMSF,
and 10 µg of leupeptin per ml). The lysates were clarified and
equivalent amounts of protein were immunoprecipitated. The immune
complexes were recovered with Sepharose CL-4B beads and heated at
95°C for 5 min. The proteins were resolved on SDS-polyacrylamide gels
and analyzed by immunoblotting. In some experiments, fusion proteins in
which SH2 domains fused to glutathione S-transferase (GST)
were used to precipitate proteins. The GST-SH2 proteins were produced
by using the pGEX-3X vector (Pharmacia) and Escherichia coli
JM109 cells and reacted with cell lysates as described previously
(35). Immunofluorescent staining for v-Abl was carried out
using cells fixed with 1% formaldehyde and the anti-v-Abl monoclonal
antibody 24-21 (41). Proteins were analyzed using
anti-Gag/v-Abl (H548) (10), anti-Shc (S14630; Transduction
Laboratories), anti-Grb2 (G16720; Transduction Laboratories), anti-p62
Dok (MMS239P [Babco] or SC6929 [Santa Cruz Biotechnology]), anti-myc (06-340; Upstate Biotechnology), antiphosphotyrosine (05-321;
Upstate Biotechnology), anti-p42/p44 MAPK (9100; New England Biolabs),
and anti-GST (SC-138; Santa Cruz Biotechnology) antibodies. Control
antibodies included rabbit gamma globulin, anti-
-2-6 fructosan
(UPC-10) (2), and anti-murine immunoglobulin (
chain).
 |
RESULTS |
Alteration of the v-Abl SH2 domain reduces NIH 3T3 cell
transformation in a temperature-dependent fashion.
To determine
the effects of an altered v-Abl SH2 domain on Ab-MLV transformation,
NIH 3T3 cells were infected with the Ab-MLV P120/R273K mutant and
monitored for transformation. Ab-MLV P120- or mock-infected cells
served as controls. Cells were examined at the standard 37°C used by
others for analogous mutants in other forms of Abl and at 34 and
39.5°C, temperatures commonly used with mammalian cells and
ts mutants. When cells infected and maintained at 34°C
were compared to sister cultures infected at 34°C and then shifted to
39.5°C for 48 h, similar levels of v-Abl proteins were recovered
(Fig. 1). All of the extracts contained
elevated levels of phosphotyrosine compared to those of mock-infected
cells (Fig. 1). Although these levels were reduced in cells infected with P120/R273K and maintained at 34°C, the reductions were more obvious when the cells were maintained at 39.5°C. Effects on some proteins (Fig. 1) were more striking, suggesting that temperature may
affect the ability of certain substrates to interact with P120/R273K.
In addition, tyrosine phosphorylation of P120/R273K itself was also
reduced.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 1.
Cells expressing P120/R273K contain low levels of
phosphotyrosine at high temperature. NIH 3T3 cells were infected with
Ab-MLV P120 or P120/R273K or were mock infected at 34°C (L); some
samples were then shifted to 39.5°C (H), and all were lysed 48 h
later. Equivalent amounts of total cellular protein were analyzed by
using Western blotting with antiphosphotyrosine antibodies or the
anti-Gag/v-Abl monoclonal antibody H548 (10). Molecular
weight standards (in thousands) are indicated on the left, and arrows
highlight bands which display temperature-dependent differences in
phosphotyrosine. The asterisk indicates the v-Abl protein.
|
|
Although cells infected with P120/R273K displayed reduced levels of
cellular phosphotyrosine at 39.5°C, typical rounded transformed
cells
could be found in the cultures. However, the frequency of
these cells
appeared to be reduced compared to that in cultures
analyzed at 34°C.
To examine this issue more fully, the transforming
titer of the viruses
was measured in a standard NIH 3T3 cell focus
assay (
40)
at all three temperatures. As expected (
18), the
titers of
P120 stocks were similar at all temperatures (Table
1). In contrast, the titer of the
P120/R273K stock was reduced
only 10-fold compared to that of the
wild-type virus at 34°C.
This difference increased to about 100-fold
when assayed at 37°C,
and the titer was 300-fold lower at 39.5°C.
Several investigators
have observed diminished transformation
frequencies with other
transforming
abl genes containing
analogous mutations (
1,
28)
using transformation assays
carried out at 37°C. However, at least
for v-Abl, the effects of the
R273K substitution are magnified
at this temperature. In addition,
given the dramatic effects of
the R273K substitution on interaction
with phosphotyrosine-containing
peptides (
28), the small
effect of the substitution on transformation
at 34°C is surprising
and suggests that interactions between isolated
SH2 domains and
peptides may not fully mimic the situation in
vivo.
As noted above, some transformed cells appeared in P120/R273K-infected
cultures maintained at 39.5°C. In addition, fully transformed
cultures of NIH 3T3 cells derived with P120/R273K at 34°C retained
a
transformed morphology when shifted to 39.5°C and were
indistinguishable
from cells transformed by the wild-type P120 strain
(data not
shown). These data reveal that the
ts phenotype of
these cells
is considerably weaker than that observed with other
ts Ab-MLV
mutants which contain substitutions within the
kinase domain,
in which case almost all the cells revert to a normal
morphology
at the nonpermissive temperature (
18).
Alternatively, during
the transformation process at 34°C additional
genetic changes
which facilitate maintenance of the transformed
phenotype at the
nonpermissive temperature may
accumulate.
Reduced binding of Shc and p62Dok to an SH2 domain with the R273K
substitution.
Even though substitutions affecting the conserved
Arg in the FLVRES motif dramatically reduce the ability of SH2 domains
to interact with tyrosine-phosphorylated peptides (3-5,
28), P120/R273K is only mildly compromised for NIH 3T3 cell
transformation at 34°C. These data could suggest that SH2 domain
interactions in vivo are more complex than can be detected by in vitro
binding assays. To explore this hypothesis, the ability of the R273K
SH2 domain to bind two v-Abl substrates, Shc and p62Dok, was tested by
using GST-SH2 fusion proteins. Shc transmits stimulatory signals via
the Grb2-Sos complex to Ras after tyrosine phosphorylation by v-Abl
(14, 27, 31, 35); tyrosine-phosphorylated p62Dok is
believed to stimulate Ras by binding the Ras suppressor p120RasGap (7, 16, 51).
As expected (
35), Shc recovered from cells transformed
with Ab-MLV P120, but not from uninfected NIH 3T3 cells, could be
precipitated by the v-Abl SH2 domain (Fig.
2A). In contrast, Shc
was precipitated
poorly by the GST-R273K/SH2 protein, with faint
interaction being
observed on prolonged exposure of the autoradiogram
(not shown).
Because binding of p62Dok to the v-Abl SH2 domain
has not been reported
previously, the GST fusion proteins used
to study Shc and others
expressing the SH2 domains of v-Src and
the Abl-related Arg protein
(
24) were used to precipitate p62Dok.
All of these
proteins interacted with p62Dok present in lysates
of Ab-MLV
P120-transformed NIH 3T3 cells or uninfected NIH 3T3
cells (Fig.
2B and
data not shown). However, binding by the GST
fusion expressing the
R273K substitution was decreased approximately
20-fold and was lower
than that observed for the Src SH2 domain.
Thus, SH2 domain interaction
with two v-Abl substrates is diminished
in the presence of the FLVRES
motif substitution, despite the
ability of P120/R273K to induce
relatively robust transformation
at 34°C.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
Shc and p62Dok bind poorly to an SH2 domain with the
R273K substitution. (A) Lysates of uninfected NIH 3T3 cells or cells
transformed with Ab-MLV P120 were incubated with GST alone, GST-SH2, or
GST-R273K SH2. The proteins were recovered and analyzed by using
Western blotting with an anti-Shc antibody. (B) Lysates of NIH 3T3
cells transformed by Ab-MLV P120 were incubated with the indicated
GST-SH2 domain fusion proteins or GST protein as a control. The
recovered proteins were analyzed by using Western blotting with an
anti-p62Dok antibody. All samples contained equivalent amounts of GST
proteins (data not shown).
|
|
Temperature-dependent transformation correlates to decreased
signals to the Ras pathway intermediates.
The discrepancy between
the in vitro binding data and the transforming potential of P120/R273K
at 34°C suggests that the binding experiments may not fully reveal
the signaling potential of the altered v-Abl protein. To explore this
issue in vivo, we examined tyrosine phosphorylation of Shc and p62Dok
in NIH 3T3 cells infected with the mutant and maintained at 34 and
39.5°C. Immunoprecipitation and Western analysis revealed that NIH
3T3 cells infected 48 h previously and incubated at 34 and
39.5°C expressed similar levels of Shc, p62Dok, and v-Abl (Fig.
3 and 4).
However, tyrosine phosphorylation of these two proteins was affected
differently in the presence of P120/R273K at the two incubation
temperatures. Tyrosine phosphorylation of Shc was decreased about
fourfold in cells infected with P120/R273K at 39.5°C compared to that
in cells expressing P120 or P120/R273K at 34°C (Fig. 3); association
with Grb2 was more strongly affected and was reduced to levels similar
to those seen in mock-infected cells. In contrast, tyrosine
phosphorylation of p62Dok was slightly decreased in cells expressing
P120/R273K at both incubation temperatures (Fig. 4). These results
suggest that signals for activation of Shc and subsequent association
of Grb2 are altered by temperature-dependent changes affecting the
P120/R273K protein. Because decreases in Shc phosphorylation appear
more modest than effects on Grb2 association, assessing tyrosine
phosphorylation levels may not fully reflect the ability of Shc to
mediate downstream signaling. However, effects on p62Dok were more
modest, suggesting that alteration of the FLVRES motif has various
effects on different v-Abl substrates and that some are more
drastically affected by temperature than others. These data also
confirm that in vitro binding does not reveal the full complexity of
interactions influenced by the SH2 domain in vivo.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Tyrosine phosphorylation of Shc and Shc-Grb2 complexes
are reduced in cells expressing P120/R273K at 39.5°C. NIH 3T3 cells
were infected with Ab-MLV P120 or P120/R273K or were mock infected and
incubated at 34°C (L) or 39.5°C (H). (A) The cells were lysed
48 h later, and a portion of the lysate was immunoprecipitated
with anti-Shc antibody or rabbit gamma globulin as a control and
analyzed by using Western blotting and antiphosphotyrosine, anti-Grb2,
and anti-Shc antibodies. Lanes labeled "Shc" contain samples
immunoprecipitated with anti-Shc antibody; lanes labeled "C"
contain samples immunoprecipitated with rabbit gamma globulin. The
antibodies used to probe the blots are listed to the right. (B) The
remaining lysate was analyzed by using Western blotting with the
anti-Gag/v-Abl monoclonal antibody H548 (10).
|
|

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 4.
Tyrosine phosphorylation of p62Dok is not temperature
dependent. NIH 3T3 cells were infected with Ab-MLV P120 or P120/R273K
or were mock infected and incubated at 34°C (L) or 39.5°C (H), and
lysates were prepared 48 h later. (A) A portion of the lysate was
immunoprecipitated with anti-p62Dok or the UPC-10 control antibody
(2) and analyzed by using antiphosphotyrosine and
anti-p62Dok antibodies. Lanes labeled "p62" contain samples
immunoprecipitated with anti-p62Dok antibody; lanes labeled "C"
contain samples immunoprecipitated with UPC-10 control antibody. The
antibodies used to probe the blots are listed to the right. (B) The
remaining lysate was analyzed by using Western blotting with the
anti-Gag/v-Abl monoclonal antibody H548 (10).
|
|
Pre-B-cell transformation by P120/R273K is temperature
dependent.
Some Ab-MLV mutants display different transformation
phenotypes in NIH 3T3 cells and pre-B cells (37). To
determine if pre-B-cell transformation by the P120/R273K mutant is also
temperature dependent, primary bone marrow cells were infected, plated
in agar or liquid medium (1, 29, 36) at 34, 37, and
39.5°C, and monitored for transformation. Liquid cultures were scored
as transformed when the cell density exceeded approximately 2 × 106 transformed cells per ml, a time at which the cells
could be subcultured; for agar assays, the frequency of macroscopic
colonies of primary transformants was determined 10 days postinfection. Bone marrow cells infected with Ab-MLV P120 became transformed at all
temperatures, and the P120/R273K mutant transformed fewer cells under
all conditions (Table 2). Between five-
and sevenfold fewer colonies were observed in agar at both 34 and
37°C. However, transformation frequencies were reduced approximately
100-fold at 39.5°C, with one to two very small pre-B-cell colonies
being observed; these cell populations could not be expanded.
Consistent with the diminished transformation potential of the
P120/R273K mutant, infected liquid cultures maintained at 34 and 37°C
became transformed later than those infected with the wild-type virus. Although some pre-B cells appeared to proliferate in several cultures infected with P120/R273K and maintained at 39.5°C, the population of
these cells could not be expanded. These data demonstrate that the
temperature-dependent transformation response found in NIH 3T3 cells
extends to pre-B cells and represents a general feature of
transformation responses to P120/R273K.
Pre-B cells transformed by P120/R273K grow poorly at elevated
temperature.
NIH 3T3 cells transformed at 34°C maintained a
transformed morphology at 39.5°C. To determine if pre-B cells
transformed by P120/R273K at 34°C could grow at 39.5°C, these cells
and controls transformed by wild-type P120 were shifted to the high
temperature, and growth was monitored by counting viable cells using
phase microscopy. Consistent with previous results (8),
cells transformed by P120 grew more rapidly at 39.5 than at 34°C,
while cells transformed with P120/R273K grew poorly at both
temperatures (Fig. 5).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Pre-B cells transformed by P120/R273K grow poorly at
39.5°C. Bone marrow cells were transformed by Ab-MLV P120 (squares)
or P120/R273K (circles) at 34°C, and primary transformants were
expanded and established. Cells were counted and seeded in 35-mm dishes
at a density of 105 cells per ml and incubated at 34°C
(open symbols) or 39.5°C (filled symbols). Duplicate cultures were
counted, and viable cells were enumerated using phase microscopy daily
for 3 days. The experiments shown are representative of at least three
experiments in which two or more cell lines transformed with each virus
were analyzed.
|
|
Unlike transformation of NIH 3T3 cells, Ab-MLV transformation of pre-B
cells is a multistep process during which cells adapt
to culture and
often acquire mutations affecting the p53 pathway
(
34,
45). These changes could affect the ability of cells
transformed
by P120/R273K to grow at 39.5°C. To test the ability
of P120/R273K to
stimulate pre-B-cell growth in the absence of
this selection, the
ability of P120/R273K to rescue the growth
of pre-B cells transformed
by the P70/H590
ts mutant was examined
(
17).
This mutant encodes a v-Abl protein containing a point
mutation within
the kinase domain; pre-B cells transformed by
this virus undergo
G
1 arrest and rapid apoptosis at the nonpermissive
temperature. However, when such cells are superinfected with wild-type
Ab-MLV, growth is restored (
17).
To monitor the effect of P120/R273K in this setting, the 7C411
ts pre-B-cell transformant was infected with wild-type virus
or P120/R273K in vectors that also contain a Neo
r gene.
Clones expressing the superinfecting viruses were selected
using G418;
immunofluorescent staining with an antibody that reacts
with
COOH-terminal determinants present in P120 and P120/R273K,
but not in
the P70 protein (
41), revealed that >90% of the cells
in
the population expressed the protein encoded by the superinfecting
virus. As expected (
8), when the cells were shifted to the
nonpermissive temperature, the parental cell line underwent
G
1 arrest and apoptosis, and the cells expressing P120
continued
to grow and displayed a cell cycle profile similar to that
found
when cells were incubated at 34°C (Table
3). Cells expressing
P120/R273K displayed
an intermediate phenotype characterized by
G
1 arrest and
diminished apoptosis. These data demonstrate that
P120/R273K fails to
transmit adequate signals to sustain growth
of pre-B cells at 39.5°C.
Expression of c-Myc is decreased at the nonpermissive
temperature.
Expression of c-Myc is required for Abl-mediated
transformation (38). Earlier studies, conducted at 37°C,
have documented that the R273K substitution reduces the ability of
v-Abl to activate expression from the E2F site in the c-myc
promoter (50, 52). To determine if the
temperature-dependent effects of P120/R273K affect the level of c-Myc
protein expression, 7C411 cells that had been superinfected with either
P120 or P120/R273K were maintained at 34°C or shifted to 39.5°C for
20 h, and lysates were prepared. Cells superinfected with the
kinase-negative mutant P120/D484N (35) and parental 7C411
cells were used as controls. In a parallel experiment, pre-B cells
transformed by P120 and P120/R273K at 34°C were examined at both
temperatures. Western analyses revealed that c-Myc expression was
diminished at 39.5°C in all of the cells expressing P120/R273K but
not in those expressing P120 (Fig. 6). These data reveal that the R273K substitution affects expression of
c-Myc, a critical downstream target of v-Abl (38), in a
temperature-dependent fashion.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 6.
Expression of c-Myc is decreased in cells expressing
P120/R273K at 39.5°C. Pre-B-cell lines transformed at 34°C by
Ab-MLV P120 or P120/R273K (A) or 7C411 parental cells (P) expressing
P120, P120/D484N, or P120/R273K (B) were maintained at 34°C or
shifted to 39.5°C for 48 h, and lysates were prepared. The
samples were analyzed via Western blotting using anti-c-Myc. The
anti-Gag/v-Abl monoclonal antibody H548 (10) was used as a
loading control in the top panel; anti-Erk antibody was used as a
loading control in the bottom panel. In panel A, three representative
pre-B-cell lines transformed with P120/R273K are shown; in panel B, two
representative clones expressing P120/R273K are shown.
|
|
 |
DISCUSSION |
These experiments identified the sequences encoding the v-Abl SH2
domain as a novel and previously unrecognized target for Ab-MLV
ts mutations. The P120/R273K mutant displays a
temperature-dependent transformation phenotype in both NIH 3T3 and
pre-B cells. Earlier work (28) had suggested a direct
correlation between the poor transformation potential of Abl proteins
containing altered SH2 domains and their ability to bind
tyrosine-phosphorylated molecules. However, only mild, 5- to 10-fold
deficiencies are found when transformation assays are carried out at
34°C, a common permissive temperature used for conditional mutants
expressed in mammalian cells. This difference is enhanced somewhat at
37°C and further magnified at 39.5°C, the temperature used for
other ts Ab-MLV mutants (18). At this
temperature, the effects of the mutation are particularly prominent in
pre-B cells, which are refractory to transformation. These data suggest
that the R273K substitution affects the structure of the
phosphotyrosine-binding pocket and perhaps the entire SH2 domain in a
temperature-dependent fashion.
Although temperature-dependent transformation is evident in both NIH
3T3 and pre-B-cell transformation assays, some transformed NIH 3T3
cells can be isolated at the nonpermissive temperature, and at least
some cells in populations transformed at the permissive temperature
retain a transformed morphology when shifted to 39.5°C. In addition,
pre-B cells that have been fully transformed with P120/R273K at 34°C
can replicate, albeit poorly, at 39.5°C. These data could indicate
that genetic or epigenetic changes that occur during the transformation
process complement transformation signals from the P120/R273K protein,
allowing the emergence of transformed cells at the nonpermissive
temperature once the transformation process is complete. Analyses of
the pre-B-cell transformation process have revealed that inactivation
of the p53 pathway is one critical step in the process (34,
45), suggesting that this event and perhaps other similar events
that may occur during NIH 3T3 cell transformation affect the
transforming potential of P120/R273K. The P120/R273K mutant should
allow further exploration of this possibility.
Substitutions affecting Arg
B5 have been studied in both Bcr/Abl and
an activated, transforming c-abl allele. In both of these
instances, transformation of immortalized fibroblasts is reduced by
several orders of magnitude at 37°C (1, 28). However, these changes have little effect on the ability of Bcr/Abl to confer
factor-independent growth on interleukin-3-dependent hematopoietic cells (12, 20, 42). Host range effects are also found in Rous sarcoma virus mutants encoding SH2 domains containing Arg
B5
substitutions or with other changes in the SH2 domain (13, 44,
47). In most of these instances, transformed chick cells are
fusiform, in contrast to the rounded cells induced by the wild-type
virus, and immortalized rodent cells are refractory to transformation
by the mutants. In two cases, large deletions removing the majority of
the v-Src SH2 domain have also been shown to confer a ts
phenotype (6).
Deficiencies in transformation by P120/R273K are correlated to
decreased levels of phosphotyrosine on many cellular proteins, as
indicated by probing whole-cell lysates with antiphosphotyrosine antibodies. Although the identity of many of these proteins is not
known, one of those affected is Shc, an intermediate involved in
v-Abl-mediated Ras activation (31, 35), an obligate
event in the transformation process (39). However,
as exemplified by p62Dok, temperature-dependent decreases in
tyrosine phosphorylation are not found on all v-Abl-responsive
proteins, perhaps reflecting temperature-dependent specificity in
SH2-mediated interactions in the presence of the R273K substitution.
Alternatively, because phosphorylation was evaluated by Western
blotting, tyrosine-phosphorylated p62Dok may be more stable than the
modified forms of Shc and other target proteins.
Analyses of multiple SH2 domain substitution mutants suggest that the
B5 Arg residue plays the dominant role in binding of tyrosine-phosphorylated residues (3-5, 28). Consistent
with these data, GST-SH2 fusions containing a Lys in place of Arg
B5 interact poorly with both p62Dok and Shc in vitro. Correlations of this
sort have suggested that decreases in transformation observed for some
SH2 domain mutants directly reflect the inability of the transforming
protein to interact with its substrates in vivo (28).
Thus, it is perhaps surprising that P120/R273K retains a strong
transforming potential at 34°C. However, similar substitutions affecting the v-Src SH2 domain have a limited effect on transformation, even though these clearly have large effects on peptide binding (3-5, 13, 44, 47). These data indicate that analyses of peptide interactions do not adequately reveal the potential for SH2
domains to participate in signaling when expressed in the context of
the rest of the protein in an in vivo setting. Future analyses of
P120/R273K may help reveal the mechanisms controlling this difference.
Study of pre-B cells transformed directly by P120/R273K at 34°C and
analyses of 7C411 cells expressing P120/R273K both suggest that signals
important for stimulation of growth are missing at 39.5°C. Among such
signals are those which activate c-Myc, another obligate intermediate
in the v-Abl transformation pathway (38). The decrease in
c-Myc levels observed at 39.5°C in cells expressing P120/R273K may
reflect the inability of P120/R273K to stimulate transcription
dependent on the E2F site in the c-Myc promoter (50, 52).
Levels of c-myc RNA are decreased in cells incubated at the
high temperature (our unpublished data), suggesting that low protein
levels reflect changes in expression of the gene. Activation of c-Myc
expression requires an active Ras protein (52), and the
decreased association of Shc and Grb2 at 39.5°C is likely to impact
Ras. The ability of P120/R273K to stimulate c-Myc expression at 34 but
not 39.5°C is also consistent with the temperature-dependent
transformation phenotype. Thus, effects on c-Myc are likely to play a
significant role in blunting the transformation response at the high temperature.
In addition to their role as docking sites for tyrosine-phosphorylated
proteins, residues within SH2 domains that contact amino acids on the
substrate molecules influence binding specificity (5, 43).
Consistent with this idea, many mutations that map to SH2 domains
confer host range effects (13, 44, 47). However, identifying the interactions that mediate these effects has been challenging. Analyses with peptides and SH2 domains with substitutions have failed to fully account for specificity (5), raising
the possibility that specificity reflects the assembly of larger, multiprotein complexes which may be affected by the subcellular localization of the kinase. The ts phenotype and the
stability of P120/R273K at the high temperature suggest that further
analysis of interactions between this protein and cellular molecules
will help illuminate the ways in which the SH2 domain contributes to Ab-MLV transformation.
 |
ACKNOWLEDGMENTS |
This work represents an equal contribution by the first two authors.
We are grateful to Henry Wortis and Larry Feig for supplying some of
the reagents used in this work.
This work was supported by CA 24420 from the National Cancer Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: SC315, Tufts
University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Phone: (617) 636-2143. Fax: (617) 636-0337. E-mail:
nrosenbe{at}opal.tufts.edu.
Present address: Department of Radiation Oncology, Brigham and
Women's Hospital, Boston, MA 02215.
Present address: Department of Hematology and Oncology, Beth
Israel Deaconess Medical Center, Boston, MA 02215.
 |
REFERENCES |
| 1.
|
Afar, D. E. H.,
A. Goga,
J. McLaughlin,
O. N. Witte, and C. L. Sawyers.
1994.
Differential complementation of Bcr-Abl point mutants with c-Myc.
Science
264:424-426[Abstract/Free Full Text].
|
| 2.
|
Auffray, C.,
J. L. Sikorav, and F. Rougeon.
1981.
Correlation between D region structure and antigen-binding specificity: evidences for the comparison of closely related immunoglobulin VH sequences.
Ann. Immunol.
132D:77-78.
|
| 3.
|
Bibbins, K. B.,
H. Boeuf, and H. E. Varmus.
1993.
Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Mol. Cell. Biol.
13:7278-7287[Abstract/Free Full Text].
|
| 4.
|
Bradshaw, J. M.,
V. Mitaxov, and G. Waksman.
1999.
Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
J. Mol. Biol.
293:971-985[CrossRef][Medline].
|
| 5.
|
Bradshaw, J. M.,
V. Mitaxov, and G. Waksman.
2000.
Mutational investigation of the specificity determining region of the Src SH2 domain.
J. Mol. Biol.
299:521-535[Medline].
|
| 6.
|
Bryant, D., and J. T. Parsons.
1982.
Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation.
J. Virol.
44:683-691[Abstract/Free Full Text].
|
| 7.
|
Carpino, N.,
D. Wisniewski,
A. Strife,
D. Marshak,
R. Kobayashi,
B. Stillman, and B. Clarkson.
1997.
p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Cell
88:197-204[CrossRef][Medline].
|
| 8.
|
Chen, Y. Y., and N. Rosenberg.
1992.
Lymphoid cells transformed by Abelson virus require the v-abl protein tyrosine kinase only during early G1.
Proc. Natl. Acad. Sci. USA
89:6683-6687[Abstract/Free Full Text].
|
| 9.
|
Chen, Y.-Y.,
L. C. Wang,
M. S. Huang, and N. Rosenberg.
1994.
An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Genes Dev.
8:688-697[Abstract/Free Full Text].
|
| 10.
|
Chesebro, B.,
K. Wehrly,
M. Cloyd,
W. Britt,
J. Portis,
J. Collins, and J. Nishio.
1981.
Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens.
Virology
112:131-144[CrossRef][Medline].
|
| 11.
|
Cohen, G. B.,
R. Ren, and D. Baltimore.
1995.
Modular binding domains in signal transduction proteins.
Cell
80:237-248[CrossRef][Medline].
|
| 12.
|
Cortez, D.,
L. Kadlec, and A. M. Pendergast.
1995.
Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.
Mol. Cell. Biol.
15:5531-5541[Abstract].
|
| 13.
|
DeClue, J. E., and G. S. Martin.
1989.
Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants.
J. Virol.
63:542-554[Abstract/Free Full Text].
|
| 14.
|
Downward, J.
1994.
The GRB2/Sem-5 adaptor protein.
FEBS Lett.
338:113-117[CrossRef][Medline].
|
| 15.
|
DuBridge, R. B.,
P. Tang,
H. C. Hsai,
P.-M. Leong,
J. H. Miller, and M. P. Calos.
1987.
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.
Mol. Cell. Biol.
7:379-387[Abstract/Free Full Text].
|
| 16.
|
Ellis, C.,
M. Moran,
F. McCormick, and T. Pawson.
1990.
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
Nature (London)
343:377-381[CrossRef][Medline].
|
| 17.
|
Engelman, A., and N. Rosenberg.
1990.
bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
Mol. Cell. Biol.
10:4365-4369[Abstract/Free Full Text].
|
| 18.
|
Engelman, A., and N. Rosenberg.
1990.
Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
J. Virol.
64:4242-4251[Abstract/Free Full Text].
|
| 19.
|
Hawley, R. G.,
F. H. Lieu,
A. Z. Fong, and T. S. Hawley.
1994.
Versatile retroviral vectors for potential use in gene therapy.
Gene Ther.
1:136-138[Medline].
|
| 20.
|
Ilaria, R. L. J., and R. A. Van Etten.
1995.
The SH2 domain of P210BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells.
Blood
86:3897-3904[Abstract/Free Full Text].
|
| 21.
|
Katz, M. E., and F. McCormick.
1997.
Signal transduction from multiple Ras effectors.
Curr. Opin. Genet. Dev.
7:75-79[CrossRef][Medline].
|
| 22.
|
Kerkhoff, E., and U. R. Rapp.
1998.
Cell cycle targets of Ras/Raf signaling.
Oncogene
17:1457-1462[CrossRef][Medline].
|
| 23.
|
Khosravi-Far, R.,
S. Campbell,
K. L. Rossman, and C. J. Der.
1998.
Increasing complexity of Ras signal transduction: involvement of Rho family proteins.
Adv. Cancer Res.
72:57-107[Medline].
|
| 24.
|
Kruh, G. D.,
R. Perego,
T. Miki, and S. A. Aaronson.
1990.
The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases.
Proc. Natl. Acad. Sci. USA
87:5802-5806[Abstract/Free Full Text].
|
| 25.
|
Lugo, T., and O. N. Witte.
1989.
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
Mol. Cell. Biol.
9:1263-1270[Abstract/Free Full Text].
|
| 26.
|
Marengere, L. E. M.,
Z. Songyang,
G. D. Gish,
M. D. Schaller,
J. T. Parsons,
M. J. Stearn,
L. C. Cantley, and T. Pawson.
1994.
SH2 domain specificity and activity modified by a single residue.
Nature (London)
369:502-505[CrossRef][Medline].
|
| 27.
|
Marshall, C.
1996.
Ras effectors.
Curr. Opin. Cell Biol.
8:197-204[CrossRef][Medline].
|
| 28.
|
Mayer, B. J.,
P. K. Jackson,
R. A. Van Etten, and D. Baltimore.
1992.
Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.
Mol. Cell. Biol.
12:609-618[Abstract/Free Full Text].
|
| 29.
|
McLaughlin, J.,
E. Chianese, and O. N. Witte.
1989.
Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.
Mol. Cell. Biol.
9:1866-1874[Abstract/Free Full Text].
|
| 30.
|
Muller, A. J.,
J. C. Young,
A.-M. Pendergast,
M. Pondel,
N. R. Landau,
D. R. Littman, and O. N. Witte.
1991.
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
Mol. Cell. Biol.
11:1785-1792[Abstract/Free Full Text].
|
| 31.
|
Owen-Lynch, P. J.,
A. K. Wong, and A. D. Whetton.
1995.
v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation.
J. Biol. Chem.
270:5956-5962[Abstract/Free Full Text].
|
| 32.
|
Parmar, K., and N. Rosenberg.
1996.
Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
J. Virol.
70:1009-1015[Abstract].
|
| 33.
|
Pendergast, A. M.,
M. L. Gishizky,
M. H. Havlik, and O. N. Witte.
1993.
SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.
Mol. Cell. Biol.
13:1728-1736[Abstract/Free Full Text].
|
| 34.
|
Radfar, A.,
I. Unnikrishnan,
H.-W. Lee,
R. A. DePinho, and N. Rosenberg.
1998.
P19Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation.
Proc. Natl. Acad. Sci. USA
95:13194-13199[Abstract/Free Full Text].
|
| 35.
|
Raffel, G. D.,
K. Parmar, and N. Rosenberg.
1996.
In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction.
J. Biol. Chem.
271:4640-4645[Abstract/Free Full Text].
|
| 36.
|
Rosenberg, N., and D. Baltimore.
1976.
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus.
J. Exp. Med.
143:1453-1463[Abstract/Free Full Text].
|
| 37.
|
Rosenberg, N., and O. N. Witte.
1988.
The viral and cellular forms of the Abelson (abl) oncogene.
Adv. Virus Res.
35:39-81[Medline].
|
| 38.
|
Sawyers, C. L.,
W. Callahan, and O. N. Witte.
1992.
Dominant negative myc blocks transformation by abl oncogenes.
Cell
70:901-910[CrossRef][Medline].
|
| 39.
|
Sawyers, C. L.,
J. McLaughlin, and O. N. Witte.
1995.
Genetic requirement for ras in the transformation of fibroblasts and hematopoietic cells by the bcr-abl oncogene.
J. Exp. Med.
181:307-313[Abstract/Free Full Text].
|
| 40.
|
Scher, C. D., and R. Siegler.
1975.
Direct transformation of 3T3 cells by Abelson murine leukemia virus.
Nature (London)
253:729-731[CrossRef][Medline].
|
| 41.
|
Schiff-Maker, L.,
M. C. Burns,
J. B. Konopka,
S. Clark,
O. N. Witte, and N. Rosenberg.
1986.
Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules.
J. Virol.
57:1182-1186[Abstract/Free Full Text].
|
| 42.
|
Skorski, T.,
A. Bellacosa,
M. Nieborowska-Skorska,
M. Majewski,
R. Martinez,
J. K. Choi,
R. Trotta,
P. Wlodarski,
D. Perrotti,
T. O. Chan,
M. A. Wasik,
P. N. Tsichlis, and B. Calabretta.
1997.
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3K/Akt-dependent pathway.
EMBO J.
16:6151-6161[CrossRef][Medline].
|
| 43.
|
Songyang, Z.,
S. E. Shoelson,
M. Chadhuri,
G. Gish,
T. Pawson,
W. G. Haser,
F. King,
T. Roberts,
S. Ratnofsky,
R. J. Lechleider,
B. G. Neel,
R. B. Birge,
J. E. Fajardo,
M. M. Chou,
H. Hanafusa,
B. Schaffhausen, and L. C. Cantley.
1993.
SH2 domains recognize specific phosphopeptide sequences.
Cell
72:767-778[CrossRef][Medline].
|
| 44.
|
Tian, M., and G. S. Martin.
1996.
Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Oncogene
12:727-734[Medline].
|
| 45.
|
Unnikrishnan, I.,
A. Radfar,
J. Jenab-Wolcott, and N. Rosenberg.
1999.
p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells.
Mol. Cell. Biol.
19:4825-4831[Abstract/Free Full Text].
|
| 46.
|
Van Parijs, L.,
Y. Refaeli,
J. D. Lord,
B. H. Nelson,
A. K. Abbas, and D. Baltimore.
1999.
Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation induced cell death.
Immunity
11:281-288[CrossRef][Medline].
|
| 47.
|
Verderame, M. F.,
J. M. Kaplan, and H. E. Varmus.
1989.
A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
J. Virol.
63:338-348[Abstract/Free Full Text].
|
| 48.
|
Waksman, G.,
S. E. Shoelson,
N. Pant,
D. Cowburn, and J. Kuriyan.
1993.
Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.
Cell
72:779-790[CrossRef][Medline].
|
| 49.
|
Warren, D.,
A. J. Heilpern,
K. Berg, and N. Rosenberg.
2000.
The carboxyl terminus of v-Abl protein can augment SH2 domain function.
J. Virol.
74:4495-4504[Abstract/Free Full Text].
|
| 50.
|
Wong, K. K.,
J. D. Hardin,
S. Boast,
C. L. Cooper,
K. T. Merrell,
T. G. Doyle,
S. P. Goff, and K. L. Calame.
1995.
A role for c-Abl in c-myc regulation.
Oncogene
10:705-711[Medline].
|
| 51.
|
Yamanashi, Y., and D. Baltimore.
1997.
Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok.
Cell
88:205-211[CrossRef][Medline].
|
| 52.
|
Zou, X.,
S. Rudchenko,
K.-K. Wong, and K. Calame.
1997.
Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases.
Genes Dev.
11:654-662[Abstract/Free Full Text].
|
Journal of Virology, February 2001, p. 1816-1823, Vol. 75, No. 4
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.4.1816-1823.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zimmerman, R. S., Rosenberg, N.
(2008). Changes in p19Arf Localization Accompany Apoptotic Crisis during Pre-B-Cell Transformation by Abelson Murine Leukemia Virus. J. Virol.
82: 8383-8391
[Abstract]
[Full Text]
-
Yi, C.-r., Rosenberg, N.
(2008). Mutations Affecting the MA Portion of the v-Abl Protein Reveal a Conserved Role of Gag in Abelson Murine Leukemia Virus (MLV) and Moloney MLV. J. Virol.
82: 5307-5315
[Abstract]
[Full Text]
-
Yi, C.-R., Rosenberg, N.
(2007). Gag Influences Transformation by Abelson Murine Leukemia Virus and Suppresses Nuclear Localization of the v-Abl Protein. J. Virol.
81: 9461-9468
[Abstract]
[Full Text]
-
Baughn, L. B., Rosenberg, N.
(2005). Disruption of the Shc/Grb2 Complex during Abelson Virus Transformation Affects Proliferation, but Not Apoptosis. J. Virol.
79: 2325-2334
[Abstract]
[Full Text]
-
Sachs, Z., Sharpless, N. E., DePinho, R. A., Rosenberg, N.
(2004). p16Ink4a Interferes with Abelson Virus Transformation by Enhancing Apoptosis. J. Virol.
78: 3304-3311
[Abstract]
[Full Text]
-
Gong, L., Unnikrishnan, I., Raghavan, A., Parmar, K., Rosenberg, N.
(2004). Active Akt and Functional p53 Modulate Apoptosis in Abelson Virus-Transformed Pre-B Cells. J. Virol.
78: 1636-1644
[Abstract]
[Full Text]
-
Unnikrishnan, I., Rosenberg, N.
(2003). Absence of p53 Complements Defects in Abelson Murine Leukemia Virus Signaling. J. Virol.
77: 6208-6215
[Abstract]
[Full Text]
-
Warren, D., Griffin, D. S., Mainville, C., Rosenberg, N.
(2003). The Extreme Carboxyl Terminus of v-Abl Is Required for Lymphoid Cell Transformation by Abelson Virus. J. Virol.
77: 4617-4625
[Abstract]
[Full Text]
-
Kim, S., Zagozdzon, R., Meisler, A., Baleja, J. D., Fu, Y., Avraham, S., Avraham, H.
(2002). Csk Homologous Kinase (CHK) and ErbB-2 Interactions Are Directly Coupled with CHK Negative Growth Regulatory Function in Breast Cancer. J. Biol. Chem.
277: 36465-36470
[Abstract]
[Full Text]